Neuron Bio, S.A.

NEU

ES0166198012

Biotechnology & Medical Research

End-of-day quote BME Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

2017	Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA.	CI
2017	Neol Biosolutions Seeks Investors	CI

Neol Biosolutions Seeks Investors

May 26, 2017 at 09:30 am IST

Neol Biosolutions, S.A. (BME:NEOL) is looking for potential investors in different units and lines of business of the company.

Latest news about Neuron Bio, S.A.

Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA.	11/17/11	CI
Neol Biosolutions Seeks Investors	26/17/26	CI
Neuron Bio, S.A. Auditor Raises 'Going Concern' Doubt	03/17/03	CI
Neuron Bio, SA completed the acquisition of 26.28% stake in NEOL Biosolutions, S.A..	23/17/23	CI
Neuron Bio, SA made an offer to acquire remaining 30.22% stake in NEOL Biosolutions, S.A. for €3.4 million.	14/16/14	CI
Neuron BioLabs, S.L. agreed to acquire diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA for €9 million.	14/16/14	CI
Neuron Bio, SA Auditor Raises 'Going Concern' Doubt	03/16/03	CI
NEOL Biosolutions, S.A. has completed an IPO in the amount of €1.55 million.	28/15/28	CI
NEOL Biosolutions, S.A. has filed an IPO in the amount of €1.55 million.	10/15/10	CI
Neuron Bio, SA Auditor Raises 'Going Concern' Doubt	05/15/05	CI
Neuron Bio, SA acquired 50% stake in NEOL Biosolutions, S.A. from Repsol, S.A. for €4.5 million.	17/14/17	CI
Neuron Biopharma, S.A. Auditor Raises 'Going Concern' Doubt	24/14/24	CI
Neuron Biopharma, S.A. Auditor Raises 'Going Concern' Doubt	30/13/30	CI
Repsol New Energy Ventures, S.A. acquired 50% stake in NEOL Biosolutions from Neuron BPh.	07/12/07	CI

Neuron BioPharma SA is a Spain-based company engaged in the biotechnology sector. The Company is active in the discovery and development of pharmaceutical compounds aimed at the prevention and treatment of various neurodegenerative diseases, with a main focus in the research on Alzheimer's disease. The Company operates also in three platforms: Drug Discovery, Pre-clinical development and Clinical development.

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
NEURON BIO, S.A.	-.--%	51.94L
VERTEX PHARMACEUTICALS INCORPORATED	+7.52%	11TCr
REGENERON PHARMACEUTICALS, INC.	+11.38%	11TCr
BIONTECH SE	-12.64%	2.22TCr
ARGENX SE	+0.44%	2.13TCr
GENMAB A/S	-4.18%	1.9TCr
WUXI APPTEC CO., LTD.	-37.85%	1.85TCr
BEIGENE, LTD.	-8.58%	1.68TCr
SAREPTA THERAPEUTICS, INC.	+37.41%	1.25TCr
LEGEND BIOTECH CORPORATION	-23.95%	808.97Cr

Bio Therapeutic Drugs

Neuron Bio, S.A.

Equities

NEU

ES0166198012

Biotechnology & Medical Research

Neol Biosolutions Seeks Investors

Latest news about Neuron Bio, S.A.

Chart Neuron Bio, S.A.

Company Profile

Sector Bio Therapeutic Drugs